Reumatoloxía
Pfizer (United States)
Nueva York, Estados UnidosPublications in collaboration with researchers from Pfizer (United States) (6)
2023
-
Etanercept Withdrawal and Retreatment in Nonradiographic Axial Spondyloarthritis: Results of RE-EMBARK, an Open-Label Phase IV Trial
Journal of Rheumatology, Vol. 50, Núm. 4, pp. 478-487
2022
2021
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
-
Subcutaneous tanezumab for osteoarthritis: Is the early improvement in pain and function meaningful and sustained?
European Journal of Pain (United Kingdom), Vol. 25, Núm. 7, pp. 1525-1539
2020
-
Subcutaneous tanezumab for osteoarthritis of the hip or knee: Efficacy and safety results from a 24-week randomised phase III study with a 24-week follow-up period
Annals of the Rheumatic Diseases, Vol. 79, Núm. 6, pp. 800-810
2014
-
Assessment of osteoarthritis candidate genes in a meta-analysis of nine genome-wide association studies
Arthritis and Rheumatology, Vol. 66, Núm. 4, pp. 940-949